The PGY-2 Infectious Diseases Pharmacy Residency program conducted by Denver Health in Denver, Colorado is accredited by ASHP.
Purpose
The purpose of the PGY-2 pharmacy residency program is to build on Doctor of Pharmacy (PharmD) education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice.
PGY-2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings.
Residents who successfully complete a PGY-2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
Description
The PGY-2 Infectious Diseases Pharmacy Residency program is a 12-month postgraduate curriculum that is designed to provide a structured learning environment and foster an in-depth learning opportunity for a resident to develop into a successful clinical pharmacy specialist.
Denver Health is an integrated, efficient, academic health care system serving as a model for other safety-net institutions across the nation. Denver Health is home to the Rocky Mountain Regional Level 1 Trauma Center for adults and Level II Trauma Center for Children, Rocky Mountain Regional Poison Center, as well as residency and fellowship training site for the University of Colorado, School of Medicine. Denver Health has also been designated by the Infectious Diseases Society of America as an Antimicrobial Stewardship Center of Excellence.
The PGY-2 Infectious Diseases resident will have the opportunity for teaching throughout their residency year, including co-precepting and mentoring PGY-1 residents and APPE students.
Opportunities to deliver infectious diseases-related lectures will be made available to the PGY-2 resident. A weekend staffing component will be required as well as a major research project with the intent to publish in a peer-reviewed journal.
The resident may participate in additional activities, including penicillin allergy testing, ED culture call back, pre-approval of restricted antimicrobials, participation in hospital committees including Antimicrobial Subcommittee, Infection Prevention Committee, and Antimicrobial Stewardship Committee, and attendance and participation in local and national meetings.
Resident Learning Experiences
The residency includes required learning experiences, elective rotations, and required longitudinal experiences.
Required Learning Experiences
- Antimicrobial Stewardship (AMS)
- AMS Teaching
- AMS / ID Consult
- ID Consult
- Orthopedic ID Consult
- Transplant ID Consult (at UCHealth)
- Medical ICU
- Denver Public Health
- Microbiology
Required Longitudinal Experiences
- Major research project and medication use evaluations
- Leadership and Clinical Practice Management
- This includes clinical staffing every third weekend (Additional moonlighting shifts may be made available to the resident dependent on resident progress and department staffing needs)
- Fellow’s Clinic
Elective Learning Experiences
- Pediatric ID (at Children’s Hospital Colorado)
- Research Design and Methodology
- ID Consult 2
- Academia (at University of Colorado Skaggs School of Pharmacy)
Application Information and Requirements
Applicants must be a PharmD graduate or candidate for graduation of an Accredited Council for Pharmacy Education (ACPE) accredited degree program, completed or in progress of completing an ASHP accredited or candidate status PGY1 Pharmacy Residency. Per ASHP Standards, residents must be licensed no later than 120 days from the start of the residency program. If not licensed by 120 days after the start of the residency program, the resident will be terminated from the program as per documentation in the acceptance letter.
Denver Health participates in the ASHP National Matching System. Applications should be submitted electronically through PhORCAS. Necessary application materials include:
- Letter of intent (maximum of 1 page) highlighting the following:
- Your goals and reason for doing an advanced PGY2 specialty residency in infectious diseases
- Why you chose to apply for the Denver Health residency program
- Your short- and long-term goals in pharmacy practice
- Your strengths and weaknesses at this point in your career and how a PGY2 residency in infectious diseases will help you develop and achieve your goals
- Curriculum Vitae
- Three letters of reference using the PhORCAS Standardized Reference Template with at least one from a preceptor who can speak to ability and/or interest in infectious diseases
- Official college of pharmacy transcript
Current PGY1 Residents at Denver Health Medical Center may early commit to a Denver Health Medical Center PGY2 Residency Program.
Resident applicants are responsible for submitting all required materials online through PhORCAS.
ASHP Code: 82033
NMS Number: 794055
Current PGY-2 Infectious Diseases Pharmacy Resident
Suki Zhan, PharmD
Dr. Zhan is from New York City. She received her Doctor of Pharmacy degree from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences and completed her PGY-1 residency at Mount Sinai Morningside and Mount Sinai West. Her interests within infectious diseases include antimicrobial stewardship, endocarditis, and managing drug-resistant organisms. Suki chose Denver Health because of its diverse patient population and unique rotation opportunities on different consult services. In her free time, Suki enjoys trying out new restaurants and bubble tea stops, watching dramas, spending time with friends and family, traveling, and playing Pokémon Go.
Major Research Project: Assessing Treatment Initiation Following Positive FLUVID Results
MUE: Evaluation of Fosfomycin Use at an Academic Safety Net Healthcare System
Contact
Kati Shihadeh, PharmD, BCIDP
Clinical Pharmacy Specialist, Infectious Diseases
PGY-2 Infectious Diseases Residency Program Director
Co-Director, Antimicrobial Stewardship Program
303-602-6986
katherine.shihadeh@dhha.org
